The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?
Though it doesn't get users high like THC-dominant products, CBD is all the rage these days due to its medical benefits and gray-area legality. On September 28, the DEA designated Epidiolex—a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government's list of controlled substances. All other CBD formulations remain...
Read in Freedom Leaf: https://apple.news/ACeGNIQuDSJWeKDJKc3L6Aw
Shared from Apple News
-Mark
No comments:
Post a Comment